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У всьому світі: майже 6 млн осіб щорічно звертаються по медичну допомогу з приводу опікових ран. На 
сьогоднішній день основним методом місцевого лікування ран та опіків, в тому числі інфікованих, є ви-
користання лікарських засобів, що містять антисептики, антибіотики, сорбенти, а також їх сполу-
чення. 
Мета. Визначити вплив композиту нанодисперсного кремнезему з полігексаметиленгуанидіну гідрохло-
ридом на імунологічні показники та показники окислювально-антиоксидантного гомеостазу у крові та 
осередку ураження щурів з неінфікованим термічним опіком. 
Матеріали і методи. Дослідження проводилося на 72 щурах, яким моделювали термічний опік ІІ ступе-
ня. Тварини були розподілені на 4 групи: інтактні, контроль, ліковані хлоргексидином, ліковані компози-
том нанодисперсного кремнезему з полігексаметиленгуанидіну гідрохлоридом. На 7-у, 14-у, 21-у та 28-у 
добу тварин виводили з експерименту та визначали імунологічні показники та показники окислювально-
антиоксидантного гомеостазу у крові та шкірі в осередку ураження. 
Результати. Термічна травма безпосередньо пов’язана з біохімічними змінами в організмі. Нами порів-
нювалися рівні проти- та прозапальних цитокінів, маркерів вільнорадикального окислення – дієнового 
коньюгату (ДК), активних продуктів тіобарбітурової кислоти (ТБК-АП), активність каталази (Кат) 
та супероксидисмутази (СОД). Було доведено, що композит НДК+ПГМГ-ГХ проявляє значно більш ви-
ражений, порівняно з хлоргексидином, фармакологічний ефект щодо зниження рівня прозапальних ци-
токінів IL-1β і TNF-α та збільшення вмісту IL-10 у крові та вогнищі термічного опіку протягом усього 
періоду спостереження. Також композит ефективно впливає на окиснювально-антиоксидантний гоме-
остаз, що виявляється нормалізацією вмісту ДК і ТБК-АП на 14-ту добу, відновленням активності Кат 
на 14-ту добу, СОД – вже на 7-му добу, порівняно з хлоргексидином.  
Висновки. Проведене дослідження свідчить про те, що композит НДК+ПГМГ-ГХ має виражені проти-
запальні та ранозагоювальні властивості, що дає змогу використовувати його як комбінований засіб для 
лікування термічних опіків 
Ключові слова: термічний опік, композит нанодисперсного кремнезему з полігексаметиленгуанидіну гід-
рохлоридом, цитокіни, окислювально-антиоксидантний гомеостаз 
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1. Introduction 
Burn injuries affect the lives of millions of people 
around the world: nearly 6 million people seek medical 
care annually. In Ukraine, 80,000 of burnt annually regis-
ter, 10 % of which are children. For local burn treatment, it 
is advisable to use antibacterial agents that promote rapid 
wound healing while reducing the risk of infection [1]. 
To date, the main method of local treatment of 
wounds and burns, including those infected, is the use of 
drugs containing antiseptics, antibiotics, sorbents, as well 
as their combination. 
However, as stated in the WHO report, "due to the 
lack of prompt and concerted action by many stakehold-
ers, the world is entering an era when antibiotics are 
losing their effectiveness, and common infections and 
minor injuries that have been treated for decades can now 
be killed again". Particular attention was given to antibi-
otic resistance of S. aureus, K. pneumoniae, E. coli,  
P. aeruginosa, which cause widespread serious illnesses, 
in particular sepsis, and play a leading role in the etiolo-
gy of burn wounds. In some countries, the incidence of 
antibiotic resistance exceeds 50 % [2]. 
Due to the increased resistance of microorganisms 
to some antibiotics, there are search for compounds that 
can be effective against them. One such compound is 
polyhexamethylene guanidine hydrochloride, which is 
used in most disinfectants in medicine and agriculture. In 
the form of hydrogels "Escalet" and "Biopag-D" poly-
hexamethylene guanidine hydrochloride is used in veter-
inary medicine to accelerate wound healing [3]. 
Polyhexamethylene guanidine hydrochloride has a 
broad spectrum of antimicrobial activity [4, 5], relatively 
low toxicity, high stability in the aquatic environment 
and in the earth [6, 7]. 
When comparing the antimicrobial action of pol-
yhexamethylene guanidine with chlorhexidine diglu-
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conate, it was found that the polymer compound had a 
greater effect on multiresistant strains of microorganisms 
in a shorter time than chlorhexidine digluconate. These 
results substantiate the feasibility of including polyhex-
amethylene guanidine hydrochloride as the main (>70 %) 
in the composition of antiseptics and disinfectants for 
acting on antibiotic resistant strains [8–10]. 
Also for the treatment of burns, it is recommended 
to use sorbents, which contribute to the reduction of 
intoxication at various stages of burn disease and the 
quickest cleansing of wounds and their preparation for 
auto-dermoplasty. This is because the sorbents are able to 
capture hundreds of millions of microbial cells and their 
toxins on their surface and thus prevent the generaliza-
tion of the infectious process. 
Highly dispersed silica is characterized by high 
sorption capacity for proteins and microorganisms, a 
wide sorption spectrum. During its application, there are 
no toxic reactions, side effects and complications. Silica-
based prolonged-release drugs provide for the gradual 
release of drugs (such as antibiotics) and their constant 
blood levels, reducing the daily dose, toxicity, and cost 
of treatment [11]. 
Therefore, to date, the development of a new 
complex drug for application sorption, which would 
affect the various parts of the wound, including burn, 
process and exhibit the properties of the sorbent, 
reparant, antimicrobial agent, becomes a very im-
portant task. 
The Department of Pharmacology of the Bo-
gomolets National Medical University and the Chuiko 
Institute of Surface Chemistry developed a composite 
of nanodispersed silica (NDS), a highly active sorbent, 
with PHMG having antimicrobial and wound healing 
properties. 
The aim of our study was to determine the effect 
of nanosized silica composite with polyhexamethylene 
guanidine hydrochloride on the immunological and redox 
indices of blood and skin in lesions in rats with uninfect-
ed thermal burn. 
During treatment, biochemical parameters of 
blood and skin in the lesion were determined, namely: 
the level of anti- and proinflammatory interleukins – IL-
1β, TNF-α, IL-10, as well as markers of free radical 
oxidation – diene conjugate (DC), thiobarbituric acid 
reactive substances (TBARS), catalase and superoxide 
dismutase activity. 
 
2. Planning (methodology) of research 
Thermal burn was modeled according to the rec-
ommendations of Yakovleva L. V. [12], under chloro-
form anesthesia. Therapy was performed with chlorhexi-
dine ("Chlorhexidine-KR" – 0.05 % solution for external 
use, PJSC "Chervona zirka", Ukraine) at doses specified 
in the instructions for use, adjusted by weight of experi-
mental animals, as well as the NDS + PHMG composite 
in predetermined doses (2000 mg / kg with a 20 % con-
tent of PHMG). For the synthesis of the composite NDS 
+ PHMG was used substance of highly dispersed silica of 
A-300 brand (LLC "Orisil-Kalush", Ukraine) and 20 % 
solution of polyhexamethylene guanidine hydrochloride 
(PC "Termit"). 
Chlorhexidine was selected as the comparison 
drug because it has antimicrobial activity and is used as 
an antiseptic for the treatment of wounds and burns. The 
NDS + PHMG composite in the study is a combination 
agent that also has a broad spectrum of antimicrobial 
activity and additionally has pronounced anti-
inflammatory properties that we investigated in this ex-
periment. 
Since the aim of the study was to determine the 
level of cytokines, markers of free radical oxidation and 
activity of catalase and superoxide dismutase, which are 
the main antioxidant enzymes, the model that most met 
the task - to determine the anti-inflammatory and antiox-
idant activity of the studied compound. This model was 
characterized by a high level of inflammatory process, 
which is confirmed by an increase in the level of proin-
flammatory cytokines, a decrease in the level of anti-
inflammatory, as well as an increase in the content of 
markers of free radical oxidation and a decrease in the 
activity of antioxidant enzymes. 
 
3. Materials and methods 
The experiment was performed on 72 outbred 
white rats, which were divided into 4 groups: intact ani-
mals, control pathology group, animals treated with 
comparative drug chlorhexidine and animals treated with 
NDS + PHMG composite. 
The animals of the experimental groups were 
simulated with a heated round metal plate on the lateral 
part of the thigh to model burns of the second degree. 
The next day after modeling in the chlorhexidine and 
NDS + PHMG groups, animals were treated and contin-
ued throughout the experiment (28 days). On the 7th, 
14th, 21st and 28th days, the animals were removed from 
the experiment and the biochemical parameters of blood 
and skin in the lesion were determined. 
Work with laboratory animals was carried out in 
accordance with the provisions of the "European Con-
vention for the Protection of Vertebrate Animals Used 
for Experimental and Other Purposes" (Strasbourg, 
18.03.86) [13], EU Directive 609 of 24.11.1986 [14], 
Law of Ukraine "On the Protection of Animals from 
Cruelty" [15] and the Order of the Ministry of Education 
and Science of Ukraine of March 24, 2012 No. 249 "On 
approval of the procedure for conducting experiments, 
experiments on animals" by scientific institutions [16]. 
The arithmetic mean (M) and standard error of the 
mean (m) were calculated on the basis of numerical val-
ues. After checking the normality of the distribution, the 
significance of the differences between the averages in 
the groups and in the dynamics from the Student's para-
metric t-test was determined. The Mann-Whitney U-test 
was used for comparative analysis of two independent 
samples from the variance of the abnormal distribution. 
Multiple comparisons were performed using ANOVA for 
normal distribution and the Kruskal–Wallis test by ranks 
for abnormal distribution. To test the significance of 
differences between the values of the variances for the 
data series, the Fisher test was used. The difference be-
tween the indicators was considered significant at the 
level of statistical significance over 95 % (p <0.05) [17]. 
Statistical processing of data was performed using the 
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computer software Statistics (Statsoft, USA) and Mi-
crosoft Office Excel (Microsoft Corp., USA). 
 
4. Results of the research 
In the control pathology group, the level of IL-1β 
in the serum was significantly increased during the entire 
observation period, its level was maximum by the 14th 
day (exceeded the intact control indicator by 2.2 times). 
By the 28th day its level gradually decreased, however, it 
did not normalize (was more by 22 % in comparison with 
intact animals) (Table 1). A similar pattern was observed 
in the lesion – its level was higher than the indicator of 
intact control throughout the experiment (Table 2). 
After use of chlorhexidine, IL-1β level was lower 
compared to the intact control group: on the 7th day – by 
9 %, on the 14th day – by 37 %, on the 21st day – by  
22 %, on the 28th day – by 20 % (Table 1). On the 7th 
day after use chlorhexidine the content of IL-1β in the 
skin was not significantly different from the 2nd group, 
on the 14th day – the level of IL-1β decreased by 22 %, 
on the 21st day – by 27 %, on the 28th day – by 20 % 
(Table 2). 
 
Table 1 
Effect of NDS + PHMG composite and chlorhexidine on the level of IL-1β (PG / ml) in serum of rats after ther-
mal burn (M±m, n=6) 
Group 
Terms of observation (days) 
7 14 21 28 
Intact 68.23±4.89 
Control 126.16±6.06* 152.39±5.02* 105.62±4.32* 83.56±2.89* 
Chlorhexidine 114.78±5.67*# 96.14±4.09*# 82.59±2.57*# 66.67±2.48# 
NDS+PHMG 94.36±5.34*#& 78.89±2.75*#& 70.56±2.56#& 63.34±1.74#& 
Note: * p <0.05 – significance of differences compared to intact; # p<0.05 – significance of differences compared to control; & 
p<0.05 – significance of differences between NDS + PHMG composite versus chlorhexidine 
 
The NDS + PHMG composite reduced the level of 
the concentration of IL-1β in the blood of rats to intact con-
trol by the 21st day, in the cell – by the 28th day (Table 1, 
2). After use of the composite, there was a decrease in the 
content of IL-1β in serum and skin on the 7th, 14th, 21st and 
28th days compared with chlorhexidine (18 % and 13.5 %, 
18 % and 35 %, 15 % and 28 %, 5 % and 5 % respectively). 
According to the results of the study in the control group, 
the content of TNF-α in the blood and hearth was higher 
compared to intact animals on the 7th day – 3.9 and 4.7 
times, on the 14th day – 3.7 and 2.8 times, and on the 21st 
day – 3 and 2 times, on the 28th day – by 41 % and 79 %, 
respectively (Table 3, 4). 
Chlorhexidine reduced the concentration of TNF-
α in the blood by 7th, 14th day.  
On the 21st and 28th days compared to the control 
by 42.5 %, 52 %, 52 % and 32 %, and in the cell by  
27.8 %, 20.7 %, 11 % and 25.3 % (Table 3, 4). 
 
Table 2 
Effect of NDS + PHMG composite and chlorhexidine on the level of IL-1β (PG / g protein) in the lesion in rats after 
thermal burn (M±m, n=6) 
Group 
Terms of observation (days) 
7 14 21 28 
Intact 34.23±3.89 
Control 78.45±3.95* 89.56±5.19* 76.88±3.21* 41.45±2.24* 
Chlorhexidine 80.18±3.19* 69.88±2.56*# 55.78±2.34*# 36.55±2.02# 
NDS+PHMG 69.33±2.38*#& 45.28±3.13*#& 39.89±2.39 *#& 34.30±1.85#& 
Note: * p<0.05 – significance of differences compared to intact; # p<0.05 – significance of differences compared to control; & 
p<0.05 – significance of differences between NDS + PHMG composite versus chlorhexidine 
 
 
Table 3 
Effect of NDS + PHMG composite and chlorhexidine on TNF-α level (PG / ml) in serum of rats after thermal 
burn (M±m, n=6) 
Group 
Terms of observation (days) 
7 14 21 28 
Intact 26.31 ±5.19 
Control 104.49±13.91* 98.13±11.58* 79.62±8.47* 44.93±5.11* 
Chlorhexidine 60.07±2.58*# 47.24±2.63*# 38.02±1.75*# 30.49±2.23# 
NDS+PHMG 47.58±2.54*#& 39.21±2.23*#& 28.73±2.31*#& 22.45±0.69#& 
Note: * p <0.05 – significance of differences compared to intact; # p <0.05 – significance of differences compared to control; & 
p<0.05 – significance of differences between NDS + PHMG composite versus chlorhexidine 
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Table 4 
Effect of NDS + PHMG composite and chlorhexidine on TNF-α (PG / g protein) level in the lesion in rats after 
thermal burn (M±m, n=6) 
Group 
Terms of observation (days) 
7 14 21 28 
Intact 4.32±0.45 
Control 20.32±2.08* 12.34±1.38* 8.69±0.49* 7.74±0.27* 
Chlorhexidine 14.67±1.32*# 9.78±0.32*# 7.73±0.46*# 5.78±0.62*# 
NDS+PHMG 8.46±0.83*#& 7.21±0.41*#& 5.32±0.18*#& 4.45±0.32#& 
Note: * – p<0.05 – significance of differences compared to intact; # p<0.05 – significance of differences compared to control; & – 
p<0.05 – significance of differences between NDS + PHMG composite versus chlorhexidine 
 
The use of the NDS + PHMG composite proved 
to be the most effective; it was found that the composite 
significantly reduced the serum TNF–α content and le-
sion compared to chlorhexidine – on the 7th day – by 
20.7 % and 42 %, on the 14th day – by 17 % and 26 %, 
by the 21st day – by 24 % and 31 %, by the 28th day – 
by 26 % and 23 %, respectively. The NDS + PHMG 
composite normalized TNF-α level both in serum and in 
the cell until the 28th day (Tab. 3, 4). 
We have shown that in case of burns there is a 
rapid decline of IL-10 levels in serum and lesions. 
Throughout the observation period, there was a gradual 
increase, but not recovery. The concentration of IL-10 in 
the blood of rats of the control group was significantly 
lower than the indicators of the intact control group on 
the 7th day – by 52.6 %, on the 14th day – by 37 %, on 
the 21st day – by 23 % and did not normalize even to the 
28th day (compared to intact animals, the level of IL–10 
was reduced by 15 %) (Table 5). In the control group, 
lesions in the IL–10 level were less by the 7th day – by 
50 %, by the 14th day – by 27 %, by the 21st day – by 
15.5 %, by the 28th day – by 9.8 % (Table 6). 
 
Table 5 
Effect of NDS + PHMG composite and chlorhexidine on IL-10 (pg / ml) level in rats serum during thermal burn  
(M±m, n=6) 
Group 
Terms of observation (days) 
7 14 21 28 
Intact 53.42 ±2.34 
Control 25.32±1.85* 33.41±4.33* 41.23±3.18* 45.42±2.73* 
Chlorhexidine 24.61±2.82* 34.67±2.72# 45.21±3.46*# 52.01±2.41# 
NDS+PHMG 33.41±1.64*#& 38.83±1.89*#& 47.21±1.62*#& 52.00±2.43# 
Note: * p<0.05 – significance of differences compared to intact; # p<0.05 – significance of differences compared to control; & 
p<0.05 – significance of differences between NDS + PHMG composite versus chlorhexidine 
 
Table 6 
Effect of NDS + PHMG composite and chlorhexidine on the level of IL-10 (PG / g protein) in the lesion in rats after 
thermal burn (M±m, n=6) 
Group 
Terms of observation (days) 
7 14 21 28 
Intact 22.41±1.85 
Control 11.12±1.34* 16.38±1.21* 18.92±2.47 20.21±1.96 
Chlorhexidine 12.64±1.44* 17.45±1.32* 19.14±3.09* 21.98±3.45* 
NDS+PHMG 15.87±1.54*# 18.46±1.32* 20.78±2.32 22.54±1.78 
Note: * p<0.05 – significance of differences compared to intact; # p<0.05 – significance of differences compared to control; & 
p<0.05 – significance of differences between NDS + PHMG composite versus chlorhexidine 
 
Level of IL-10 on the 7th day in blood and skin 
under the influence of chlorhexidine remained virtually 
unchanged compared to the intact control group (53 % 
and 44 %, respectively, lower than normal). On the 14th 
day the concentration of IL-10 in blood and skin was 
higher when using chlorhexidine compared to the control 
by only 3.7 % and 6.5 %, respectively. At day 21, the 
level of IL-10 in the blood was slightly higher when 
using chlorhexidine compared to the control by 9.6 %, in 
the skin was not significantly different. On day 28, 
chlorhexidine normalized the content of IL-10 in the 
blood and skin of rats undergoing burns. The comparison 
drug increased the concentration of IL-10 in the blood by 
14.5 % relative to control; when using chlorhexidine in 
the skin the indicator was not significantly different from 
the group without treatment (Table 5, 6). 
The most pronounced effect on the content of IL-
10 in the blood and lesion had the composite NDS + 
PHMG. The use of the test composite resulted in a faster 
and significantly increased level of IL-10 in the blood 
and skin compared to the control throughout the study 
(Table 5, 6). Under the influence of the composite NDS 
+ PHMG on the 7th, 14th and 21st days, the concentra-
tion of IL-10 in the blood was higher compared to chlor-
hexidine – by 36 %, 12 % and 4 %, respectively. At day 
28 after use of the composite, the level of IL-10 in the 
blood of rats was not significantly different from the 
level of IL-10 in the group of the comparator. When 
Scientific Journal «ScienceRise: Pharmaceutical Science»                                                                     №4 (20)2019 
 
49 
using the composite NDS + PHMG level of IL-10 in the 
cell increased already on the 7th day compared with 
chlorhexidine – by 25.5 %. 
In rats with thermal burn there was activation of 
free radical processes in the lesion occurred during the 
whole period of the experiment (Table 7, 8). There has 
been an intensification of the process of lipid peroxida-
tion (LPO) and the increase of its primary – diene conju-
gate (DC) and secondary products - thiobarbituric acid 
reactive substances (TBARS). 
The content of DC and TBARS exceeded the 
norm by 7 % on the 7th day by 78 % and 66 %, on the 
14th day by 61 % and 79 %, on the 21st day by 42.5 % 
and 42 %, on the 28th day by 36 % and 27.2 % respec-
tively. Both studied indicators in this group did not nor-
malize even on the 28th day. 
Chlorhexidine reduced the content of DC and 
TBARS in the lesion compared with control on the  
7th day by 20 % and 13.1 %, on the 14th day – by 19 % 
and 23.3 %, on the 21st day – by 14 % and 12,8 %, on 
the 28th day – by 17 % decreased the level of DC, the 
values of the level of TBARS did not differ significantly 
compared with the control (Table 7, 8). 
 The use of NDS + PHMG composite proved to 
be much more effective, since the composite normalized 
the content of DC and TBARS in the skin of animals as 
early as the 14th day. The level of DC and TBARS de-
creased compared to the level of DC in the group chlor-
hexidine on the 7th day – by 13.6 % and 11.9 %, on the 
14th day – by 13 % and 13.5 %, on the 21st day – by 
12.9 % and 9 %, on the 28th day – by 11.2 % and  
14.5 %, respectively (Table 7, 8).  
 
Table 7 
Effect of NDS + PHMG composite and chlorhexidine on the level of DC (μmol/g) in the lesion in rats after thermal 
burn (M±m, n=6) 
Group 
Terms of observation (days) 
7 14 21 28 
Intact 14.12±2.18 
Control 25.24±1.11* 22.78±1.45* 20.12±1.86* 19.21±1.13* 
Chlorhexidine 20.21±1.46*# 18.43±2.11*# 17.29±1.12*# 15.97±1.42# 
NDS+PHMG 17.46±2.34*#& 16.02±2.13# 15.06±1.36# 14.18±1.13# 
Note: * p <0.05 – significance of differences compared to intact; # p <0.05 – significance of differences compared to control;  
& p <0.05 – significance of differences between NDS + PHMG composite versus chlorhexidine 
 
 
Table 8 
Effect of NDS + PHMG composite and chlorhexidine on TBARS content (nmol /g) in the lesion in rats after thermal 
burn (M±m, n=6) 
Group 
Terms of observation (days) 
7 14 21 28 
Intact 5.01 ± 0.35 
Control 8.32±0.45* 8.98±0.12* 7.11±0.56* 6.89±0.71* 
Chlorhexidine 7.23±0.21*# 6.89±0.32*# 6.20±0.06*# 5.94±0.43* 
NDS+PHMG 6.37±0.34*# 5.96±0.41*#& 5.64±0.23*#& 5.08±0.13#& 
Note: * p <0.05 – significance of differences compared to intact; # p <0.05 – significance of differences compared to control;  
& p <0.05 – significance of differences between NDS + PHMG composite versus chlorhexidine 
 
A concurrent study of the antioxidant system in 
the respective animal groups found that in rats with 
thermal burns, the activity of the antioxidant enzymes in 
the skin was lower in comparison to intact animals. The 
activity of catalase (Cat) and superoxide dismutase 
(SOD) was not restored even until the 28th day of the 
experiment and decreased in comparison to intact ani-
mals on the 7th day by 64 % and 27.2 %, on the 14th day 
by 50 % and 24 , 3 %, on the 21st day – by 26.5 % and 
14.7 %, on the 28th day – by 14 % and 17.1 % respec-
tively (Table 9, 10). 
Compared to controls, chlorhexidine increased the 
level of Kat in the skin on the 7th, 14th, 21st and 28th 
days by 45.5 %, 16.3 %, 6 % and 13.8 %, respectively. 
The normalization of Cat activity when using chlorhexi-
dine was observed on the 28th day (Table 9). 
 
Table 9 
Effect of NDS + PHMG composite and chlorhexidine on Cat (conventional units) activity in the lesion in rats after 
thermal burn (M±m, n=6) 
Group 
Terms of observation (days) 
7 14 21 28 
Intact 4.03 ± 0.09 
Control 1.45±0.37* 2.02±0.32* 2.96±0.29* 3.47±0.41* 
Chlorhexidine 2.11±0.13*# 2.35±0.15* 3.14±0.22# 3.95±0.34# 
NDS+PHMG 2.38±0.23*# 3.63±0.31*#& 3.92±0.14#& 4.03±0.03# 
Note: * p<0.05 – significance of differences compared to intact; # p<0.05 – significance of differences compared to control; & 
p<0.05 – significance of differences between NDS + PHMG composite versus chlorhexidine 
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More pronounced effect of chlorhexidine had on 
the activity of SOD, normalizing its level in the lesion 
center of rats with burn wound on the 14th day  
(Table 10). Chlorhexidine increased SOD activity com-
pared to the untreated group by 12.1 % on the 14th day, 
by 14.7 % on the 21st day, and no significant differences 
were observed on the 28th day. The maximum activation 
of the antioxidant system was observed with the NDS + 
PHMG composite – Cat activity was restored on the skin 
on the 14th, SOD on the 7th day. The use of the compo-
site led to an increase in the activity of Cat compared 
with chlorhexidine on the 14th day by 54.5 % (Table 9). 
Compared with chlorhexidine, SOD activity in 
the skin of rats with thermal burns increased by  
11.4 % (on the 14th day) when applied with the com-
posite (Table 10). 
 
Table 10 
Effect of NDS + PHMG composite and chlorhexidine on SOD activity (conventional units) in the lesion in rats after 
thermal burn (M±m, n=6) 
Group 
Terms of observation (days) 
7 14 21 28 
Intact 4.56±0.63 
Control 3.32±0.12* 3.45±0.17* 3.61±0.34 3.78±0.26 
Chlorhexidine 3.42±0.19* 3.87±0.33* 4.14±0.48 4.61±0.43 
NDS+PHMG 3.79±0.31# 4.31±0.68# 4.51±0.21# 4.58±0.3# 
Note: * p<0.05 – significance of differences compared to intact; # p<0.05 – significance of differences compared to control; & 
p<0.05 – significance of differences between NDS + PHMG composite versus chlorhexidine 
 
5. Discussion of the results 
The study showed that thermal burns have a viola-
tion on the oxidative-antioxidant homeostasis. Free radi-
cal oxidation processes are activated, which leads to 
intensification of lipid peroxidation processes and deple-
tion of the antioxidant system. The NDS+PHMG compo-
site effectively influenced the oxidation-antioxidant ho-
meostasis indices, restoring them by the middle of the 
observation period, indicating its high antioxidant prop-
erties, which is provided by the nanodispersed silica. The 
NDS absorbs tissue breakdown products and removes 
them, accelerating wound repair. 
The level of proinflammatory cytokines in the 
blood and lesion in untreated rats was higher than intact 
controls throughout the observation period, and IL-10 
levels were reduced. After the use of chlorhexidine, the 
level of IL-1β and TNF-α both in the blood and in the 
lesion decreased almost to normal and the level of IL-10 
increased. The use of the NDS + PHMG composite led to 
more significant changes in these parameters, normaliz-
ing them, which also indicates the anti-inflammatory 
properties of the compound. 
As the literature does not describe the effect of the 
NDS + PHMG composite on burn wound healing, im-
munological parameters, and oxidative antioxidant ho-
meostasis, we can compare our findings with those of the 
composite components. 
According to the literature, in the treatment of 
burn wounds in experimental animals, the poly-
hexymethylene guanidine hydrogel showed greater 
wound healing activity compared to the reference drug 
Levomecol, resulting in a greater reduction in wound 
surface area on the 10th day of treatment. Wound healing 
after application of polyhexamethylene guanidine was 
faster than in control animals treated with placebo (sodi-
um chloride solution) locally. The drug increased the 
amount of antioxidants in the blood, normalized the con-
tent of leukocytes in the peripheral blood [18]. 
Similar results were also obtained with the use 
of polyhexamethylene guanidine in linear skin and 
muscle wounds. The drug normalized the number of 
leukocytes in the peripheral blood and had antioxidant 
activity [19]. 
In the case of nanosized silica alone, the epithe-
lialization of the wound was observed in mice that 
were simulated with grade III-B infected burn for  
24 days [20]. 
With the use of composite silica with metronida-
zole, the incidence of postoperative complications, such 
as suppuration of the surgical wound and suture differ-
ences decreased, and the healing time of purulent wounds 
of different localization was reduced. Moreover, the 
antimicrobial activity of metronidazole in the composite 
even increased compared to monodrugs due to the sorp-
tion of microorganisms [11]. 
Since microorganisms that colonizing the affected 
area play a significant role in the development of compli-
cations after thermal burns, it is important to use non-
resistant antimicrobials. Therefore, the use of mechanical 
sorption in the face of increasing antibiotic resistance is 
extremely important. In the experiments, it was proved 
that highly dispersed silica is adsorbed on the surface of 
the microorganism and leads to their agglutination. In 
addition, highly dispersed silica neutralizes the adhesive 
properties of the bacterial cell, which impedes biofilm 
formation and subsequent wound infection [21]. 
Other authors also note significant antibacterial, 
wound healing and sorption properties of sorbents based 
on highly dispersed silica with antibacterial preparations 
immobilized on its surface for the treatment of purulent 
surgical wounds, abscesses and phlegmon of soft tissues 
in the complex treatment of purulent complications [22]. 
In addition, the use of complex composite of high-
ly dispersed silica with levofloxacin on the model of 
infected thermal burn contributed to a faster normaliza-
tion of lipid peroxidation and antioxidant system, which 
may testify to the powerful antioxidant, anti-
inflammatory and antimicrobial properties of experi-
mental [23]. 
Analyzing the experimental and clinical results, 
we concluded that it is advisable to create a nanocompo-
site with the inclusion of an antimicrobial antioxidant 
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polyhexamethylene guanidine and nanodispersed silica, 
which can enhance the antimicrobial properties of the 
polymer and reduce its toxicity. Nanosilica in the compo-
site is able to provide lymphosanation and protect intact 
tissues from hypoxia, as well as to prevent absorption of 
polyhexamethylene guanidine, which will reduce the 
toxicity of the composite. Further in-depth studies of the 
anti-inflammatory, wound-healing and metabolic proper-
ties of the new nanodispersed silica composite with pol-
yhexamethylene guanidine will provide new data on its 
mechanism of action and pharmacodynamics, and outline 
the prospects of its use for wound healing therapy. 
Limitations of the study. Because the NDS + 
PHMG composite was applied in suspension and the 
wound area was not covered by a bandage to prevent loss 
of active components due to the interaction of animals 
with the environment, the therapeutic effect of the com-
posite may be diminished. 
A further limitation was that the study was per-
formed on a model of uninfected thermal burn, while 
usually burns are accompanied by infection and the re-
sults of treatment may vary, including the time of nor-
malization of immunological and oxidative-antioxidant 
homeostasis. 
In addition, research is a stage of preclinical study 
of the effectiveness of a new composite on the burn 
wound model in rats, and it is impossible to accurately 
extrapolate the results to a similar thermal burn model in 
humans. 
6. Conclusions 
The NDS + PHMG composite exhibits a much 
more pronounced pharmacological effect, compared to 
chlorhexidine, in reducing the level of the proinflamma-
tory cytokines IL-1β and TNF-α and increasing the IL-10 
content in the blood and the site of thermal burn during 
the entire observation period. In addition, the composite 
effectively affects the oxidative-antioxidant homeostasis, 
which is manifested by the normalization of the content 
of DC and TBASP on the 14th day, restoration of Cat 
activity on the 14th day, SOD – on the 7th day, compared 
with chlorhexidine. 
Composite NDS + PHMG effectively reduces the 
level of proinflammatory and increases the level of pro-
inflammatory cytokines, indicating the presence of anti-
inflammatory properties, as well as antioxidant, since the 
composite also normalized the oxidative-antioxidant 
homeostasis by normalizing the content of markers of 
free radical oxidation and oxidation to accelerate the 
treatment of thermal burns. 
The results lead to a more detailed study of the 
anti-inflammatory and antioxidant properties of the NDS 
+ PHMG composite. However, based on the obtained 
results, it is possible to recommend a composite for the 
treatment of burn wounds and prevention of infectious 
complications. 
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